Evidence map›Paper›PMID 35013982›Full record

ReviewDrug delivery and translational research2022

Critical parameters for design and development of multivalent nanoconstructs: recent trends.

Avijit Kumar Bakshi, Tanweer Haider, Rahul Tiwari, Vandana Soni

Abstract readReview
In one paragraph

Review in Drug delivery and translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Avijit Kumar BakshiDepartment of Pharmaceutical Sciences, Dr. Harisingh Gour University, Madhya Pradesh, Sagar, 470003, India.
Tanweer HaiderDepartment of Pharmaceutical Sciences, Dr. Harisingh Gour University, Madhya Pradesh, Sagar, 470003, India.ORCID 0000-0002-7391-815X
Rahul TiwariDepartment of Pharmaceutical Sciences, Dr. Harisingh Gour University, Madhya Pradesh, Sagar, 470003, India.ORCID 0000-0003-3704-3445
Vandana SoniDepartment of Pharmaceutical Sciences, Dr. Harisingh Gour University, Madhya Pradesh, Sagar, 470003, India. vsoni@dhsgsu.edu.in.ORCID 0000-0002-4118-0779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A century ago, the groundbreaking concept of the magic bullet was given by Paul Ehrlich. Since then, this concept has been extensively explored in various forms to date. The concept of multivalency is among such advancements of the magic bullet concept. Biologically, the concept of multivalency plays a critical role in significantly huge numbers of biochemical interactions. This concept is the sole reason behind the higher affinity of biological molecules like viruses to more selectively target the host cell surface receptors. Multivalent nanoconstructs are a promising approach for drug delivery by the active targeting principle. Designing and developing effective and target-specific multivalent drug delivery nanoconstructs, on the other hand, remain a challenge. The underlying reason for this is a lack of understanding of the crucial interactions between ligands and cell surface receptors, as well as the design of nanoconstructs. This review highlights the need for a better theoretical understanding of the multivalent effect of what happens to the receptor-ligand complex after it has been established. Furthermore, the critical parameters for designing and developing robust multivalent systems have been emphasized. We have also discussed current advances in the design and development of multivalent nanoconstructs for drug delivery. We believe that a thorough knowledge of theoretical concepts and experimental methodologies may transform a brilliant idea into clinical translation.

Indexed as

Receptors, Cell SurfaceCell MembraneLigandsLigandsReceptors, Cell SurfaceDesign and developmentDrug deliveryMultivalencyMultivalent nanoconstructsQuantification

Identifiers

PMID35013982
PMCPMC8747862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.